Cargando…
First person – Ling-shiang Chuang
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Ling-shiang (Felix) Chuang is first author on ‘Zebrafish modeling of intestinal injur...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737957/ http://dx.doi.org/10.1242/dmm.041624 |
_version_ | 1783450750574133248 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Ling-shiang (Felix) Chuang is first author on ‘Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease’, published in DMM. Ling-shiang is an instructor in the lab of Judy Cho at Icahn School of Medicine at Mount Sinai, New York, USA, investigating how to establish human genetic-driven personalized drug treatments for inflammatory bowel disease (IBD) by using zebrafish as a screening model. |
format | Online Article Text |
id | pubmed-6737957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-67379572019-09-12 First person – Ling-shiang Chuang Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Ling-shiang (Felix) Chuang is first author on ‘Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease’, published in DMM. Ling-shiang is an instructor in the lab of Judy Cho at Icahn School of Medicine at Mount Sinai, New York, USA, investigating how to establish human genetic-driven personalized drug treatments for inflammatory bowel disease (IBD) by using zebrafish as a screening model. The Company of Biologists Ltd 2019-08-01 2019-08-13 /pmc/articles/PMC6737957/ http://dx.doi.org/10.1242/dmm.041624 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Ling-shiang Chuang |
title | First person – Ling-shiang Chuang |
title_full | First person – Ling-shiang Chuang |
title_fullStr | First person – Ling-shiang Chuang |
title_full_unstemmed | First person – Ling-shiang Chuang |
title_short | First person – Ling-shiang Chuang |
title_sort | first person – ling-shiang chuang |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737957/ http://dx.doi.org/10.1242/dmm.041624 |